因特格控股
ITGR
126.70
-0.02
-0.02%
因特格控股
US · ITGR
#2239 按市值排名
上市于 1970
126.70
-0.02
-0.02%
实时 - 追踪5344个代码 - 心跳于412秒前
· 2026-10-16 19:30
✦ 量化股权信号 计算方式说明
减持
- 最近一期（2026/Q3）披露持股的机构数量减少了1家。
- 机构持股总比例下降了0.9个百分点。
机构持股
- 机构持股比例
- 121.08% -0.85pp
- 机构数量
- 386 -1
- 数据截至
- 2026/Q3 较上一报告期
持股变动 vs 资金流向
方向一致机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。
机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。
持股人类型
Mutual Fund83.92%
Hedge Fund14.86%
Public Company14.51%
Private Company3.56%
Government Pension Fund3.56%
Individual/Insider0.98%
Insurance Company0.33%
Family Office/Trust0.17%
Sovereign Wealth Fund0.15%
主要股东 截至 2026-06-30
BlackRock
15.75% · 5.35M 股
Invesco Ltd.
6.28% · 2.13M 股
Vanguard Portfolio Management, LLC
6.00% · 2.04M 股
Vanguard Capital Management, LLC
5.17% · 1.76M 股
Dimensional Fund Advisors
4.79% · 1.63M 股
Nomura Holdings, Inc.
4.57% · 1.55M 股
State Street Global Advisors
4.16% · 1.41M 股
Irenic Capital Management LP
3.72% · 1.26M 股
EARNEST Partners, LLC
2.97% · 1.01M 股
Hudson Bay Capital Management LP
2.94% · 1.00M 股
条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。
内部人持股
共追踪50份申报 · 27次买入 · 22次卖出
| 姓名 | 职务 | 持股比例 |
|---|---|---|
| Payman Khales | President of Cardio & Vascular | 0.18% |
| Pamela Bailey | Independent Chairperson | 0.16% |
| William Summers | Independent Director | 0.13% |
| Filippo Passerini | Independent Director | 0.09% |
| M. Maxwell | Independent Director | 0.07% |
| Donald Spence | Independent Director | 0.06% |
| Diron Smith | Chief Financial Officer | 0.04% |
| Cheryl Capps | Independent Director | 0.03% |
| Sheila Antrum | Independent Director | 0.03% |
| John Harris | Former Vice President of Operations - Cardio & Vascular | 0.03% |
内部人交易 最近的 Form 4 申报记录
| 日期 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-09-14 | Kirk Thor | Executive Vice President | Open Market Disposition | -31,540 | $126.23–126.25 |
| 2026-09-14 | Kirk Thor | Executive Vice President | Intent to Sell (Form 144) | -4,700 | $126.30 |
| 2026-09-10 | Kirk Thor | Executive Vice President | Intent to Sell (Form 144) | -31,540 | $126.20 |
| 2026-09-07 | Andrew Senn | Senior Vice President of Strategy, Business Development & Investor Relations | Open Market Disposition | -9,408 | $126.30 |
| 2026-06-29 | Kirk Thor | Executive Vice President | Derivative Exercise and Sale | -2,409 | $93.45 |
| 2026-06-29 | Kirk Thor | Executive Vice President | Derivative Exercise and Retained | +3,711 | -- |
| 2026-06-28 | John Harris | Former Vice President of Operations - Cardio & Vascular | Other Derivative Acquisition | +1,096 | -- |
| 2026-05-19 | Michael Coyle | Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Filippo Passerini | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | M. Maxwell | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | James Hinrichs | Independent Director | Other Derivative Acquisition | +1,967 | -- |
| 2026-05-19 | Donald Spence | Independent Director | Other Derivative Acquisition | +2,623 | -- |
| 2026-05-19 | James Flanagan | Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Sheila Antrum | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Alvin Jeffers | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Cheryl Capps | Independent Director | Other Acquisition | +1,967 | -- |
| 2026-05-19 | Aaron Kapito | Director | Other Acquisition | +1,967 | -- |
| 2026-05-17 | Tom Thomas | VP, Corporate Controller & Principal Accounting Officer | Other Derivative Acquisition | +666 | -- |
| 2026-05-14 | Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | Derivative Exercise and Sale | -479 | $88.16 |
| 2026-05-14 | Jim Stephens | President of Cardiac Rhythm Management & Neuromodulation | Derivative Exercise and Retained | +1,484 | -- |
Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。
报价时间 2026-10-16 19:30:05 · 仅供参考，不构成投资建议，也未考虑您的具体情况。
因特格控股 讨论区 0 条评论